Search Results
Search this site
191 results found
- Peptide Complexes: Unlocking the Power of Skin Signalling
Peptide complexes are blends of short chains of amino acids designed to interact with the skin. Found in serums, creams and treatments, they are often positioned as “active” ingredients targeting firmness, wrinkles, pigmentation and repair. Unlike traditional ingredients that mainly hydrate or protect at the surface, peptides work by influencing how skin behaves. They help guide key processes within the skin, offering a more targeted and considered approach to skincare. What we know Peptides are short amino acid chains that can mimic fragments of natural skin proteins, triggering biological responses linked to repair and regeneration 1. Different peptide types perform distinct roles. Signal peptides stimulate collagen and elastin production, carrier peptides deliver trace elements such as copper, and neurotransmitter-inhibiting peptides can soften expression lines 1, 2. Peptides also influence inflammation, pigmentation and barrier function, linking them to a wide range of skin concerns beyond ageing 3, 4. When combined into complexes, peptides can act across multiple pathways, supporting more comprehensive and targeted skin responses 1, 2, 3. Industry impact and potential Peptide complexes are shifting skincare towards more targeted, mechanism-led innovation: Mechanism-driven design: Building peptide combinations around defined biological pathways rather than marketing-led blends. From single actives to systems: Using complementary peptides to influence multiple processes, from collagen synthesis to inflammation. Advanced delivery strategies: Improving stability and penetration to ensure peptides reach viable skin layers. Our position At Sequential, we provide insight into how peptide complexes shape skin biology by integrating peptide research with multi-omic and microbiome analysis, supporting the development of formulations designed for real-world impact. Using our global database of 50,000+ samples, we help brands see how peptide-based products work in the skin, supporting the development of formulations that lead to real, long-term skin health improvements. References Pintea, A, et al. (2025). Peptides: Emerging Candidates for the Prevention and Treatment of Skin Senescence: A Review. Biomolecules, 15, (1), 88. Ngoc, L, et al. (2023). Insights into Bioactive Peptides in Cosmetics. Cosmetics, 10, (4), 111. Mao, Z. (2025). Frontiers in Skin Rejuvenation: Recent Advances in Anti-Aging Skincare Technologies Based on Proteins, Peptides, and Peptide Derivatives. Modern Health Science, 8 (1), 69. Zhao, X, et al. (2021). Collagen peptides and the related synthetic peptides: A review on improving skin health. Journal of Functional Foods, 86, 104680.
- Sebum Metabolomics: Beyond Oil, Towards Insight
Sebum metabolomics is the study of the small molecules and lipids present in sebum, the oily substance produced by the skin. While often associated only with oiliness or acne, sebum is a biologically active mixture that reflects what is happening within the skin. By analysing sebum, it is possible to capture a chemical snapshot of skin function. This offers a non-invasive way to understand processes such as inflammation, barrier changes and microbiome activity, as well as how skin responds to environmental factors and skincare products. What we know Sebum is composed of triglycerides, free fatty acids, wax esters, squalene and cholesterol, playing a key role in barrier function, antimicrobial defence and protection against environmental stressors 1. Metabolomic analysis can map hundreds of molecules within sebum, providing a detailed profile of skin biology using simple, non-invasive sampling methods 2. Sebum reflects both internal processes and external exposures, linking it to inflammation, microbiome activity, hormonal changes and environmental impact 3. Distinct sebum profiles have been linked to conditions such as acne, sensitivity and barrier dysfunction, supporting its role as a biomarker of skin health 1, 3. Industry impact and potential Sebum metabolomics is enabling a shift towards more precise, data-driven skincare: Skin profiling and diagnostics: Using sebum as a non-invasive readout to better classify skin states and risks. Product evaluation: Measuring how formulations change skin at a molecular level, beyond visible effects. Targeted formulation design: Developing products that address underlying drivers such as lipid imbalance, inflammation and microbiome shifts. Our position At Sequential, our multi-omic approach captures metabolomic changes at the skin surface, providing insight into sebum composition and how it responds to products in real-world conditions. By capturing how formulations influence sebum composition, we help brands develop targeted, evidence-led skincare grounded in measurable change. Using our global database of 50,000+ samples, we support the development of formulations that respond to individual skin needs, moving beyond surface-level effects towards more precise, long-term skin health outcomes. References Géhin, C., Tokarska, J., Fowler, S., Barran, P., & Trivedi, D. (2023). No skin off your back: the sampling and extraction of sebum for metabolomics. Metabolomics, 19. https://doi.org/10.1007/s11306-023-01982-3. Zhang, J., Wu, F., Wang, J., Qin, Y., & Pan, Y. (2024). Unveiling the Metabolomic Profile of Oily Sensitive Skin: A Non-Invasive Approach. International Journal of Molecular Sciences, 25. https://doi.org/10.3390/ijms252011033. Isom, M., & Desaire, H. (2024). Skin Surface Sebum Analysis by ESI-MS. Biomolecules, 14. https://doi.org/10.3390/biom14070790.
- Keratosis Pilaris: More Than Just Rough Skin
Keratosis pilaris (KP) is one of the most common yet misunderstood skin conditions. Often presenting as rough texture on areas like the arms, thighs or buttocks, it is medically harmless and can be frustrating to live with. Frequently dismissed as dry skin and treated with simple moisturisers or harsh exfoliation, it can persist despite consistent care. For many people, this can lead to a cycle of over-treating the skin, increasing irritation without addressing the underlying texture. As awareness of skin comfort and barrier-friendly care grows, there is increasing recognition that KP requires gentle, sustained support rather than quick or aggressive fixes. What we know KP is a disorder where keratin builds up and blocks hair follicles, sometimes trapping hairs and causing rough, bumpy skin appearance 1. KP is linked to abnormalities in the pilosebaceous unit which is the hair follicle's structural unit, comprised of the hair follicle and its associated sebaceous gland and arrector pili muscle 2. KP commonly begins in childhood or adolescence and can affect up to 50–80% of adolescents and ~40% of adults, with notable impacts on skin confidence and quality of life 3. Industry impact and potential KP presents a clear opportunity for skincare innovation beyond basic moisturisation and exfoliation: Barrier-first formulations: Products that support barrier repair alongside gentle keratolysis to improve texture without irritation. Smarter exfoliation systems: Balanced use of acids, urea and moisturising ingredients to smooth skin without causing irritation over time. Combination approaches: Using exfoliation, hydration and follicle-focused care rather than relying on single solutions. Education-led care: Setting realistic expectations, as KP often requires sustained, consistent management rather than quick fixes. Our position At Sequential, we help brands look beyond surface smoothing claims and understand how their products actually affect the skin barrier and hair follicles in real-world use. By combining microbiome profiling with molecular, metabolomic and multi-omic analysis, we can assess how products influence skin texture, keratin build-up and skin barrier resilience over time. Using our global database of 50,000+ samples, we can support the development of evidence-led formulations that target the biological drivers of KP rather than short-term cosmetic appearance alone. References Hwang, S. et al. (2008). Keratosis pilaris: a common follicular hyperkeratosis. Cutis, 82, 177–180. Reddy, S. et al. (2021). Role of acids, steroids and kinase inhibitors in keratosis pilaris. Cureus, 13, e18917. Wang, J. et al. (2018). Keratosis pilaris and therapeutic options. Am J Clin Dermatol, 19, 733–757.
- The Perimenopausal Shift in Skin and Scalp Biology
Perimenopause brings profound, hormone-driven changes to skin and scalp biology, yet these shifts are still dismissed as “ageing.” For many people, the experience is sudden and unsettling: skin that once felt predictable becomes dry or reactive; hair begins to thin, shed or change texture; the scalp becomes itchy or persistently irritated. These changes can arrive quickly, without warning or clear guidance on what is happening or why. As conversations around menopause become more open, there is growing recognition that perimenopausal skin and scalp need different support. These are not cosmetic inconveniences but biological transitions shaped by fluctuating hormones and individual physiology. Understanding what changes during this phase is essential for developing products that respond to underlying biology, not just visible symptoms. What we know Falling and fluctuating oestrogen levels, alongside a relative rise in androgens, alter collagen production, barrier integrity and sebum regulation, contributing to dryness, sensitivity and reduced elasticity ¹. Hair follicles are oestrogen-responsive; reduced oestrogen shortens the growth phase, leading to increased shedding, finer hair and slower regrowth, often most visible at the temples and crown ². Hormonal shifts combined with scalp skin ageing (reduced collagen, vascularity and barrier function) increase susceptibility to irritation, inflammation and microbiome imbalance, contributing to thinning and discomfort ³. Around 60–70% of women report skin changes and up to 80% report hair symptoms during perimenopause, with wide variation in timing and severity, making one-size-fits-all solutions ineffective ¹. Industry impact and potential Perimenopause opens new opportunities for targeted innovation: Life-stage specific care: Products designed around hormonal transitions rather than chronological age. Scalp-first approaches: Supporting barrier health and follicle environments alongside hair fibres. Long-term support: Moving beyond quick fixes to sustained skin and scalp resilience. Broader hormone insight: Expanding research beyond oestrogen to include hormones such as progesterone. Our position At Sequential, we help brands understand how perimenopausal skin and scalp respond under real-world conditions. By combining microbiome profiling with molecular, metabolomic and multi-omic analysis, we can track changes in barrier function, inflammation and follicle-relevant pathways over time. Using our global database of 50,000+ samples, we can benchmark responses across life stages to support products that genuinely meet perimenopausal needs. References Zouboulis, C. et al. (2022). Skin, hair and beyond: the impact of menopause. Climacteric, 25, 434–442. Kamp, E. et al. (2022). Menopause and hair disorders. Clin Exp Dermatol, 47, 2110–2116. Williams, R. et al. (2020). Hair ageing and the follicle environment. Exp Dermatol, 29, 588–597.
- Cheap Cosmetic Testing Is Costing You Millions. Here’s the Math.
Most cosmetic brands want the same thing: faster launches, lower costs and stronger claims. But there is a costly mistake: choosing the cheapest available test and expecting it to support the biggest possible promise. The problem is not cheap testing. It is expecting evidence built for screening to prove outcomes it was never designed to measure. What does “cheap” cosmetic testing actually deliver? Low-cost testing provides valuable information during development. A package around £1,000 can determine whether a formulation remains stable, and whether it causes irritation under controlled conditions; however, such tests rarely demonstrate complex outcomes. They do not prove barrier improvement, microbiome restoration, reduced visible ageing or a clinically meaningful benefit. Why do underpowered studies fail? Claims require evidence that matches the promise. Many weak studies fail not because the study design cannot answer the question the claim requires. Problems often include small participant numbers, the absence of an appropriate control group, testing individual ingredients rather than the finished product, or extending conclusions beyond what was actually measured. The important thing is whether the evidence can withstand scrutiny from regulators, retailers and increasingly informed consumers. What happens when a claim is challenged? The cost of weak evidence is rarely limited to the testing fee. A challenged claim can require removal of advertising, delayed launches, additional studies and damage to retailer confidence. A £10,000 saving becomes a six-figure problem when a flagship claim fails. How does multi-omics compare on a cost-per-claim basis? Multi-omics is more expensive because it answers deeper questions: what changed, why it changed and whether those changes relate to consumer outcomes. For complex claims involving microbiome health or personalised skincare, it can strengthen evidence and reduce uncertainty. It does not replace clinical studies but helps explain the mechanisms behind observed effects. What price range buys regulator-defensible evidence? The right investment depends on the claim; there is no universal price for regulator-defensible evidence. Lower-risk claims may need only safety, stability and basic evaluation (£5,000–£20,000), while breakthrough claims involving microbiome modulation, anti-ageing or biological repair require stronger human evidence, objective measurements and potentially microbiome or biomarker analysis. Controlled human studies can start from £40,000. Where can brands legitimately save? Smart savings come from matching evidence investment to product risk. Brands can reduce unnecessary costs by using early screening approaches to refine formulations, eliminate weaker candidates before expensive studies begin, and focus deeper evidence generation on their most commercially important products. The mistake is spending less and expecting the evidence to prove more. The goal is to invest in the right evidence at the right stage.
- The 12 Mechanisms Of Aging
The reality is, we are all aging. But what is the exact biological impact of this process on the skin? Modern longevity science has moved beyond surface-level aesthetics, mapping out precisely what happens at a cellular level as humans age [1]. For brands, formulators, and professionals in the dermatology and cosmetics space, understanding these biological root causes is essential for developing the next generation of scientifically-backed products [2]. The Biological Criteria for Aging Before exploring specific mechanisms, it is important to understand how scientists classify these biological processes. To be officially recognised as a "hallmark" of aging, a physiological process must meet three strict criteria [3]: Age-associated manifestation: The biological issue must clearly appear and progressively worsen as organisms get older. Acceleration by experimental accentuation: If intentionally triggered or worsened in a laboratory setting, it must cause rapid, accelerated physical aging. Opportunity for intervention: If a therapeutic or cosmetic treatment targets this specific problem, it must result in a measurable slowing or reversal of aging markers. The 12 Hallmarks of Aging: An Overview In 2013, the foundational "Hallmarks of Aging" were defined by researchers. Over the past decade, extensive scientific validation expanded this list, bringing the total to twelve fundamental processes in 2023 [3]: Fig 1. The Hallmarks Of Aging Deep Dive: 5 Crucial Mechanisms Driving Skin Aging For personal care and cosmetics formulation, certain biological hallmarks have a substantial impact on the skin's visible aging timeline. Here is a closer look at the five mechanisms that represent the frontier of longevity skincare. 1. Chronic Inflammation ("Inflammaging") What it is: "Inflammaging" is the result of long-lasting, low-level inflammation throughout the body. Over time, this constant state of stress makes it much harder for the skin to heal and renew itself [3,4]. Why it matters for skin: This causes the skin to break down its collagen and elastin, weaken its protective barrier, and heal much slower, directly leading to wrinkles, sagging, dryness, and an uneven tone. Fig 2. Inflamm-aging in the Skin 2. Dysbiosis What it is: Dysbiosis is a structural imbalance within the skin’s microbiome. In a healthy state, diverse populations of beneficial microorganisms coexist to protect the skin [5]. Why it matters for skin: As we age, our skin's physical composition undergoes significant changes that alter the "microenvironment" where these microbes live. This factor causes: Decreased Lipid Production: A reduction in natural oils (sebum) removes a primary nutrient source for beneficial bacteria. Diminished Hydration: Lower moisture levels create a drier, more difficult environment for microbes to survive. Barrier Fragility: A weakened physical defense layer makes the skin more susceptible to external stressors (like UV damage) and instability [6]. (fig. 3) Fig 3. Impact of the Skin Microbiome on Wrinkle Formation and Potential Modulation During Aging 3. Altered Intercellular Communication What it is: To stay healthy, the body's cells constantly send messages to each other. As you age, this communication breaks down, weakening the immune system and making it harder for the body to heal and protect itself [3]. Why it matters for skin: Healthy skin relies on different layers of cells talking to each other to produce collagen and keep the skin strong. When this communication breaks down, the skin struggles to heal or protect itself from sun damage, which leads to a weaker barrier and easier bruising [7]. 4. Loss of Proteostasis What it is: Proteostasis is the cells' recycling center, responsible for building and breaking down proteins (collagen, elastin and keratin). When it stops working properly, damaged proteins pile up and create a mass amount of toxic cellular waste [3]. Why it matters for skin: The buildup of this cellular waste creates an unhealthy environment that weakens the cells. As a result, the skin loses its natural radiance and its ability to remain firm and elastic [8]. 5. Epigenetic Alterations What it is: Picture DNA as the permanent blueprint of the body; the epigenome acts as the switches that turn specific genes on or off based on our environment and lifestyle. As we age, the mechanisms controlling these switches begin to fail, preventing genes from operating as efficiently as they did in youth [3]. Why it matters for skin: Rather than just being a symptom of getting older, shifts in the epigenome actively drive the skin's aging process. Fortunately, scientists can map these genetic switches to evaluate exactly how well certain topical treatments work, allowing us to see if a product can genuinely decelerate aging within the cells [9]. Where does Sequential fit in? Today, consumers demand "healthspan" and "skin longevity" products that target root biological causes rather than acting as temporary cosmetic fixes [12]. Targeting complex issues like chronic inflammation and microbiome imbalance requires highly advanced, active formulations. More importantly, regulatory bodies and modern consumers require strict, physiological proof of efficacy. Testing these advanced claims in standard petri dishes or skin models fails to capture the full interconnected picture of how we age on a biological level. This is where Sequential Bio steps in. Sequential's multi-omic platform integrates multiple layers of biological data to provide a holistic view of a formula’s performance: SNP Detection: Maps a consumer's unique DNA to reveal their natural baseline for skin aging, such as their likelihood to develop wrinkles. It helps predict how a consumer will respond to specific ingredients. This takes the guesswork out of formulation, empowering you to create highly personalized, science-backed product lines that you know will work. Microbial Gene Expression: Uncover how genes are activated in response to treatments. This gives in depth- insight into how the skin's surface reacts to your formulation. Proteomics: Measures the complete protein profile (elastin, keratin and collagen) of the skin to track how product impacts the cellular function and structural integrity. This gives you definitive proof that your product rebuilds and maintains the skin’s structure. By shifting away from simple observational studies and toward deep-level multi-omic biological validation, Sequential's multi-omic platform validates what's happening at the molecular level, giving personal care and dermocosmetic brands proof of biological mechanism; not just efficacy, but clear, and actionable data. The future of longevity skincare isn't about concealing age; it’s about biological validation. The focus has shifted to the mechanism of action. Consumers want to know what is happening at a molecular level: what is your product actually doing beyond the surface? References Haykal, D. et al. (2025) 'Advances in longevity: The intersection of regenerative medicine and cosmetic dermatology', Journal of Cosmetic Dermatology. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12268380/ (Accessed: 28 April 2026). Klinngam, W. et al. (2025) 'Longevity cosmeceuticals as the next frontier in cosmetic innovation: A scientific framework for substantiating product claims', Frontiers in Aging, 6. Available at: https://doi.org/10.3389/fragi.2025.1586999 (Accessed: 29 April 2026). López-Otín, C. et al. (2023) 'Hallmarks of aging: An expanding universe', Cell, 186(2), pp. 243-278. Available at: https://doi.org/10.1016/j.cell.2022.11.001 (Accessed: 29 April 2026). Gabriel, N. (2025) 'Inflammaging: How chronic inflammation accelerates visible aging', Ultimate Cosmetics. Available at: https://www.ultimatecosmetics.com.au/blog/inflammaging (Accessed: 28 April 2026). Borrego-Ruiz, A. and Borrego, J.J. (2024) 'Microbial dysbiosis in the skin microbiome and its psychological consequences', Microorganisms. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC11433878/ (Accessed: 28 April 2026). Challa, V. et al. (2025) 'Microbiome–aging–wrinkles axis of skin: Molecular insights and microbial interventions', International Journal of Molecular Sciences, 26(20), p. 10022. Available at: https://www.mdpi.com/1422-0067/26/20/10022 (Accessed: 28 April 2026). Lifespan.io (no date) Altered Intercellular Communication. Available at: https://lifespan.io/topic/altered-intercellular-communication/ (Accessed: 29 April 2026). Skin Organoids in Proteostasis Research: Early Insights into Aging (2025). Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12961993/ (Accessed: 29 April 2026). Booth, L.N. and Brunet, A. (2016) 'The aging epigenome', Molecular Cell, 62(5), pp. 728-744. Available at: https://pubmed.ncbi.nlm.nih.gov/27259204/ (Accessed: 29 April 2026). Agrawal, R., Hu, A. and Bollag, W.B. (2023) 'The skin and inflamm-aging', Biology, 12(11), p. 1396. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10669244/ (Accessed: 29 April 2026). Lancôme (2026) Lancôme Booklet. Available at: https://www.science.org/cms/asset/522c73c5-09e4-4279-96eb-8f764c08dc9c/_20260316_cpub_lancome_booklet.pdf (Accessed: 29 April 2026). Vogue (2026) 2026's biggest skincare trends to try now. Available at: https://www.vogue.com/article/2026s-biggest-skincare-trends-to-try-now (Accessed: 29 April 2026).
- Why everyone’s talking about Tranexamic Acid
Tranexamic acid (TXA) has gained significant attention in skincare for its ability to treat hyperpigmentation by interrupting both pigment formation and pigment driven inflammation. Originally used medically to reduce bleeding, TXA inhibits plasma activity, a pathway recognised as relevant in pigment regulation. Its long clinical history means TXA enters cosmetic skincare with a stronger evidence base than many commonly used brightening ingredients. As its use grows, understanding how TXA performs within real formulations and on different skin types is essential for credible product development. What We Know: TXA (oral, intradermal and topical) improves melasma and other forms of hyperpigmentation, with significant reductions in MASI scores when compared to baseline or control (Calacattawi,et al, 2024). TXA decreases UV-induced melanocyte signalling, helping limit excess melanin production (Minasyan et al, 2024). TXA disrupts pigment transfer from melanocytes to keratinocytes, improving post-inflammatory hyperpigmentation (Chen et al, 2024). Topical TXA is well tolerated and can be paired with treatments such as microneedling, to enhance results, offering a safer alternative to stronger agents like hydroquinone (Konisky et al, 2023). Industry Impact and Potential: TXA’s multi-pathway action offers advantages for product development; Broad applicability -> Effective across varied pigmentation concerns including melasma, post inflammation hyperpigmentation and general uneven tone. Good tolerability -> Suitable for sensitive skin when formulated at low concentrations. Synergistic formulating -> Pairs well with niacinamide, vitamin C derivatives and retinoids for complementary pathways. Our Position: At Sequential, we help brands move from “TXA is trending” to “here is exactly what TXA is doing in this formula, on this skin.” We can help uncover what TXA is actually doing once it enters a full product system, how it interacts with other actives, whether it reaches relevant biological pathways, and how skin responds over time. Using our in-vivo testing frameworks, microbiome-aware models and multi-omic platforms, we can map changes in pigment biology, inflammation, and barrier behaviour . Our global database of 50,000+ samples allows us to benchmark TXA-containing formulations against diverse skin types, tones and real-world microbiome profiles, revealing who benefits most and why. References: Calacattawi, R. et al. (2024). Tranexamic acid for melasma: meta-analysis of RCTs. J Dermatol Treat, 35. Chen, T. et al. (2024). Tranexamic acid for hyperpigmentation disorders: an update. Clin Cosmet Investig Dermatol, 17, 2151–2163. Konisky, H. et al. (2023). Tranexamic acid in melasma: administration routes. J Cosmet Dermatol, 22, 1197–1206. Minasyan, M. et al. (2024). Oral tranexamic acid for PIH prevention and treatment. Dermatol Surg, 50, S219–S224.
- Proteomics: The Hidden Layer of Skincare You Never See
Proteomics is the large-scale study of proteins, how they are expressed, modified and interact with the body. In skincare, proteomics is emerging as a powerful tool to understand how products influence skin function at a molecular level. Proteins play an important part in many skin processes and by analysing them, offers a more accurate picture of skin health, deeper than surface level observations alone. Unlike genomics, proteomics captures which proteins are present and active under specific conditions. What We Know: Proteomic analysis can identify shifts in structural proteins (e.g., keratin, filaggrin, collagen) associated with barrier strength and elasticity (Ma et al, 2020). Longitudinal proteomic monitoring reveals how products influence ageing pathways, including oxidative stress responses and collagen degradation (McCabe et al, 2020). Proteomics helps differentiate between short-term cosmetic effects and deeper, biologically meaningful changes (Benoit et al, 2023). Proteomics can be combined with microbiome data to show how protein changes relate to shifts in microbial activity, giving a clearer picture of overall skin health (Roux et al, 2021). Industry Impact and Potential: Proteomics opens new opportunities for product development; Targeted formulations: By identifying protein level changes, more precise ingredient selection for specific skin concerns can occur. Personalised skincare: Proteomic fingerprints may help tailor products to individual biological responses rather than general skin types. Credible product claims: By combining proteomics with clinical endpoints, formulators can link specific protein changes directly to visible and functional outcomes. Our Position: At Sequential, we move beyond generic claims to generate clear, defensible evidence of biological impact. By integrating proteomic analysis with microbiome and multi-omic data from our global database of 50,000+ samples, we can determine exactly how formulations influence skin function over time. Our approach focuses on real-world evidence, quantifying changes in protein expression, barrier integrity and resilience, to support the development of products grounded in measurable outcomes rather than marketing terminology. References: Benoit, I. et al. (2023). A proteome-centric view of skin ageing and age-related pathways. Clin Cosmet Investig Dermatol, 16, 79–85. Ma, J. et al. (2020). Quantitative proteomics analysis of young and elderly skin. Aging (Albany NY), 12, 13529–13554. McCabe, M. et al. (2020). Alterations in extracellular matrix composition during ageing. Matrix Biology Plus, 8. Roux, P. et al. (2021). Integrative multi-omics reveals microbe–metabolite clusters linked to skin health. J Invest Dermatol.
- Beyond pH
For years, intimate care has relied on pH balancing as a measure of safety. However, pH alone does not protect vaginal ecosystems. Microbiome profiles differ widely between women based on hormones, ethnicity, contraceptive use, hygiene habits and life stage. Even pH-aligned products can still disrupt balance, reduce protective lactobacilli or slow recovery, leading to discomfort or recurring symptoms. What We Know; Research highlights that: • Vaginal microbiomes differ significantly between individuals and life stages, yet these variations can remain healthy (Condori-Catachura et al., 2025). • Preservatives, surfactants and fragrance compounds can reduce lactobacillus dominance even when pH remains within recommended ranges (Han et al., 2021). • Microbial recovery after disruption, particularly following antibiotic use or infection treatment, can take weeks and with increased reoccurrence risks (Lehtoranta et al., 2020). • “Gentle” or “pH-balanced” claims do not reliably protect against dysbiosis; true safety depends on strain-level preservation (Valeriano et al., 2024). Industry Impact and Potential; Understanding these shifts means brands can now design products that better reflect real user needs: • Lifecycle aligned solutions for key phases such as postpartum recovery, peri-menopause, or post-antibiotic care, where microbial disruption is most pronounced. • More honest, evidence-based claims, moving beyond vague words like “gentle” or “pH-balanced” and focusing on real microbiome support. • Clear guidance for users, helping people choose products that fit their unique microbiome or life stage, instead of assuming everyone needs the same thing. Our Solution: Sequential evaluates how intimate-care products affect the vaginal microbiome in real use. Using qPCR, 16S, ITS and metagenomics, and drawing on a database of 50,000+ microbiome profiles, we measure effects on lactobacillus dominance, disruption and recovery over time. This evidence raises the standard for microbiome-safe intimate care, moving beyond pH-based claims toward solutions rooted in real biological protection. References: Condori-Catachura, S. et al. (2025) Diversity in women and their vaginal microbiota. Trends in Microbiology, 33(11), 1163-1172. https://doi.org/10.1016/j.tim.2024.12.012 Han, Yet al., 2021. Role of Vaginal Microbiota Dysbiosis in Gynecological Diseases and the Potential Interventions. Frontiers in Microbiology, 12. https://doi.org/10.3389/fmicb.2021.643422 . Lehtoranta, L.,et al. (2020). Recovery of Vaginal Microbiota After Standard Treatment for Bacterial Vaginosis Infection: An Observational Study. Microorganisms , 8 (6), 875. https://doi.org/10.3390/microorganisms8060875 Valeriano, V., et al., 2024. Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics. Frontiers in Microbiomes. https://doi.org/10.3389/frmbi.2024.1363089 .
- The Hidden Stress Of City Skin
City living exposes skin to constant, invisible stress such as pollutants, heavy metals and airborne microbes. This exposure changes the behaviour of the skin in terms of 1) how well it tolerates ingredients, 2) how quickly irritation appears, and 3) how long recovery takes after disruption. These changes are not just theoretical, research consistently shows measurable biological differences in pollution-exposed skin. What We Know: Research demonstrates that continuous pollution exposure leads to measurable biological changes: • Pollution alters microbial structure, reducing protective commensal species and favouring opportunistic organisms, leading to less stable microbial communities and increased reactivity (Yan et al, 2025). • Airborne particulate matter drives lipid oxidation, producing inflammatory lipid metabolites that contribute to dullness and uneven tone, while also altering ingredient absorption and sensory feel (Araviiskaia, et al., 2019). • Heavy metals disrupt immune signalling, prolonging recovery cycles and delaying restoration of hydration, transepidermal water loss and microbiome diversity after irritation or exfoliation (Misra, et al., 2021). Industry Impact and Potential: This presents a great opportunity for brands to create produces which genuinely respond to urban skin stress, such as: • Cleansers that remove pollutants without stripping beneficial microbes. • Repair serums that protect lipids both dryness and oxidation. • Ingredient combinations designed to reduce irritation and better support the skin barrier. • Region-specific formulations tailored to pollution levels, humidity or season. Our Solution: At Sequential we can quantify how pollution exposure alters microbial behaviour, lipid balance and recovery timelines using real-world testing. Through sequencing, biomarker profiling and multi-omic analysis, we can support you to compare urban vs non-urban responses, identifying disruption risks and resilience markers. With a global database of 50,000+ profiles across diverse climates and skin types, we help brands validate microbiome-safe formulations and turn environmental claims into measurable, defensible outcomes grounded in biological evidence. References: Araviiskaia, E., et al. (2019). The impact of airborne pollution on skin. Journal of the European Academy of Dermatology and Venereology, 33, pp. 1496 - 1505. https://doi.org/10.1111/jdv.15583 . Misra, N., et al. (2021). Multi-omics analysis to decipher the molecular link between chronic exposure to pollution and human skin dysfunction. Scientific Reports, 11. https://doi.org/10.1038/s41598-021-97572-1 . Yan, D., et al. (2025). Particulate matter pollution alters the bacterial community structure on the human skin with enriching the Acinetobacter and Pseudomonas.. Ecotoxicology and environmental safety, 294, pp. 118061 . https://doi.org/10.1016/j.ecoenv.2025.118061 .
- Inside-out Skincare
The gut and skin are connected through shared metabolic, immune and microbial pathways. When the gut microbiome becomes imbalanced, it can heighten systemic inflammation, worsening visible concerns such as acne, eczema, excess oil, redness and slow healing. Likewise, when the skin barrier is compromised, this can influence gut immune tolerance and increase reactivity to foods or environmental triggers. Rather than operating separately, gut and skin act as interacting ecosystems that influence each other’s stability. What we know: Evidence shows that gut–skin interactions are measurable and biologically meaningful: • Gut dysbiosis correlates with inflammatory skin conditions and slower recovery trajectories, meaning people with disrupted gut microbiota often experience more persistent or recurring flare-ups (Thye et al, 2022). • Probiotics can help the skin, but not everyone responds in the same way (Mahmud et al, 2022). • Compounds produced in the gut can impact the skin’s oil levels, moisture, inflammation and repair processes (Jimenez-Sanchez, et al, 2025). Industry impact and potential: Understanding the gut–skin connection gives brands an opportunity to move beyond surface-only products and address internal factors that influence skin balance. This enables more integrated inside–out solutions, rather than isolated topical treatments. This creates new possibilities such as: • Paired ingestible-and-topical routines where supplements complement barrier-supportive skincare • Bioactives that target internal flare triggers, such as probiotics or postbiotics used alongside barrier supportive skincare. • Timed product cycles for specific skin stages, including barrier reset, seasonal dryness support, or dedicated acne management stages . Our solution: Sequential enables brands to understand the gut-skin connection through real-world testing. Using cutting edge research techniques, we can track how changes in gut microbial composition translate into measurable shifts in skin outcomes. Using our global database of over 50,000 microbiome profiles, we are able to explore who responds, who doesn’t, and why. This insight sets a new standard for microbiome-informed skincare, moving beyond surface-only approaches and toward solutions grounded in the biology of the whole system. References Jimenez-Sanchez, M., et al. (2025) The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential. https://doi.org/10.1080/19490976.2025.2473524 Mahmud , M. R., et al. (2022) Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. https://doi.org/10.1080/19490976.2022.2096995 Thye, A. Y-K., et al. (2022) Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis. https://doi.org/10.3390/biomedicines10051037
- From Surface Cleaning to Precision Care
Introduction Periodontal disease arises from a disruption of the normal bacterial balance in the oral cavity, leading to chronic inflammation of the gingiva and, in advanced cases, irreversible damage to the supporting tissues of the teeth. Gingivitis, the early and reversible stage, affects a large proportion of adults worldwide and can progress to periodontitis if left unmanaged. Globally, periodontal disease represents a significant public health burden, contributing to disability, reduced quality of life, and substantial economic costs. Its development is closely linked to the accumulation of mature dental biofilms driven by inadequate oral hygiene, which promotes the overgrowth of pathogenic bacteria. Species such as Porphyromonas gingivalis , Tannerella forsythia , Fusobacterium nucleatum , Prevotella species, and Actinomyces are consistently associated with disease onset and progression (Hu et al. , 2024). Given the central role of bacterial dysbiosis in periodontal disease, oral care products have been developed to target plaque accumulation and inflammation using ingredients with antimicrobial or modulatory properties, such as chlorhexidine, cetylpyridinium chloride, stannous fluoride, zinc salts, hydrogen peroxide, and prebiotic agents like arginine. While some of these ingredients demonstrate clear clinical benefits, particularly for gingivitis control, their precise effects on bacterial function and virulence remain incompletely understood. Emerging transcriptomic research suggests that different ingredients can selectively alter bacterial gene expression, influencing metabolic pathways, stress responses, and virulence-related mechanisms. A deeper understanding of how specific oral care ingredients affect pathogenic bacteria at the molecular level is therefore essential for the rational design of more effective formulations (Hu et al. , 2024). Article: The Effect of Oral Care Product Ingredients on Oral Pathogenic Bacteria Transcriptomics Through RNA-Seq (Hu et al., 2024) The gene expression activity of six representative periodontal pathogenic bacteria: Actinomyces viscosus, Streptococcus mutans, Porphyromonas gingivalis, Tannerella forsythia, Fusobacterium nucleatum, and Prevotella pallens was measured using RNA sequencing (RNA-Seq) following exposure to nine common ingredients found in toothpaste and mouthwash, these being: stannous fluoride, stannous chloride, arginine bicarbonate, cetylpyridinium chloride, sodium monofluorophosphate, sodium fluoride, potassium nitrate, zinc phosphate, and hydrogen peroxide. This allows for an improved understanding of how individual oral care ingredients are able to influence bacterial activity, and allows for assessment of the effectiveness of each ingredient against the six bacterial species (Hu et al. , 2024). Results Analysis of the different treatments revealed stannous fluoride, stannous chloride, and hydrogen peroxide to have the most significant effects in reducing bacterial gene expression, with stannous chloride and hydrogen peroxide being among the most potent ingredients for inhibiting gene expression in all tested bacteria, and cetylpyridinium chloride reducing expression in almost all bacteria, with the exception of F. nucleatum . Inhibition of gene expression was significantly greater in the group receiving treatment with these ingredients compared to the no-treatment control group, indicating the effectiveness of these compounds in restricting bacterial growth and activity. Transcriptomic analysis of bacterial gene expression found significant inhibition of the lipopolysaccharide (LPS) biosynthesis pathway in response to stannous chloride, stannous fluoride, and cetylpyridinium chloride use, with LPS molecules involved in bacterial cell membrane formation where they can act to trigger inflammation, tissue destruction, and bone loss associated with gingivitis and periodontal disease. These results indicate an ability of these compounds to work to downregulate bacterial genes associated with this pathway, and further restrict pathogen growth. Gene expression analysis also revealed a significant downregulation of infection-related genes in response to sodium fluoride, stannous chloride, and stannous fluoride, which has the effect of also reducing the virulence of the different bacteria. Bacterial degradation enzymes involved in the breakdown of host tissues and proteins to trigger inflammation and periodontal disease were also investigated via gene expression analysis. Results indicated a downregulation of these genes, particularly in response to stannous compounds, cetylpyridinium chloride, and sodium fluoride, with enzymes like hemolysin, which plays a role in red blood cell destruction and tissue damage, and collagenase, which allows bacteria to penetrate connective tissue and induce inflammation being significantly inhibited in response to these ingredients (Hu et al. , 2024). Conclusion The results of this study provide strong evidence to suggest the application of certain oral care product ingredients can significantly disrupt or alter the transcriptomic and metabolic activity of a variety of oral periodontopathogenic bacteria, with compounds like stannous fluoride, stannous chloride, and cetylpyridinium chloride being the most potent and players in triggering gene expression changes that lead to the inhibited growth and pathogenic activity of these bacteria, thus reducing their overall virulence and ability to trigger changes in the physical oral environment that induce progression of periodontal disease (Hu et al. , 2024). Strengths and Limitations of Research Strengths Allows for a more holistic discernment of how different chemical treatments can influence biological function by providing a community-wide perspective of how different microorganisms can respond to individual chemicals within oral care products rather than focusing on a single species or set of genes. By providing such a mechanistic understanding of these chemicals’ modes of action, it can allow for screening and ranking of ingredients for more efficient product formulations, as well as identifying compounds that hit different targets or different pathogens, further guiding product design (Hu et al. , 2024). Limitations Many of these studies still rely on 16S rRNA sequencing as a way to classify and determine compositional properties of the oral microbiome instead of high-throughput methods like shotgun metagenomic sequencing, limiting the resolution with which these microbial groups can be identified, and restricting the depth of functional gene analysis and exploration that can be achieved. This, therefore, limits the level of functional characterisation of oral biofilms that can be achieved using omics approaches (Xie et al. , 2025). Future Directions and Research Single-cell sequencing technologies can be implemented alongside existing multiomics approaches to enable the study of less abundant species of bacteria present within oral biofilms, as well as enabling targeted isolation and investigation of individual cell behaviors within complex microbial communities. This can provide further insight into health-disease markers associated with specific strains, and allow characterisation of the ecological profiles of previously unknown oral microbes and their response to various oral care products/formulations (Lin et al. , 2024). Conclusion Periodontal disease reflects a complex interplay between pathogenic bacteria, host responses, and environmental influences, with dysregulated microbial activity driving inflammation and tissue destruction. Growing evidence shows that oral care ingredients can influence not only bacterial survival but also key molecular pathways linked to virulence, immune activation, and tissue degradation. By modulating bacterial gene expression involved in processes such as endotoxin production, host tissue breakdown, and infection-related mechanisms, targeted formulations have the potential to reduce pathogenicity. Advancing molecular and multi-omics approaches offers a valuable framework for understanding these interactions at greater depth, supporting the development of more precise oral care strategies that better preserve oral health and help prevent disease progression. References Hu, P. et al. (2024) ‘The Effect of Oral Care Product Ingredients on Oral Pathogenic Bacteria Transcriptomics Through RNA-Seq’, Microorganisms , 12(12), p. 2668. Available at: https://doi.org/10.3390/microorganisms12122668 . Lin, Y. et al. (2024) ‘Omics for deciphering oral microecology’, International Journal of Oral Science , 16(1), p. 2. Available at: https://doi.org/10.1038/s41368-023-00264-x . Xie, Q. et al. (2025) ‘Comprehensive Analysis of Orthodontic Treatment Effects on the Oral Microbiome, Metabolome, and Associated Health Indicators’, International Dental Journal , 75(3), pp. 1585–1598. Available at: https://doi.org/10.1016/j.identj.2025.02.014 .











